Reference : The TNF/ADAM 17 system: implication of an ADAM 17 haplotype in the clinical response ...
Scientific congresses and symposiums : Paper published in a journal
Human health sciences : Laboratory medicine & medical technology
Human health sciences : General & internal medicine
http://hdl.handle.net/2268/5283
The TNF/ADAM 17 system: implication of an ADAM 17 haplotype in the clinical response to infliximab in Crohn's disease
English
Dideberg, Vinciane mailto [Centre Hospitalier Universitaire de Liège - CHU > > Génétique >]
Theatre, Emilie [Université de Liège - ULg > > Génétique générale et humaine >]
Farnir, Frédéric mailto [Université de Liège - ULg > Département de productions animales > Biostatistique, économie, sélection animale >]
Vermeire, Séverine [UZ Gasthuisberg > Department of Gastroenterology >]
Rutgeerts, Paul [UZ Gasthuisberg > Department of Gastroenterology >]
De Vos, Martine [UZ Gent > Department of Gastroenterology >]
Belaiche, Jacques mailto [Université de Liège - ULg > Département des sciences cliniques > Hépato-gastroentérologie]
Franchimont, Denis [Erasme University Hospital > Department of Gastroenterology >]
Van Gossum, André [Erasme University Hospital > Department of Gastroenterology >]
Louis, Edouard mailto [Université de Liège - ULg > Département des sciences cliniques > Hépato-gastroentérologie >]
Bours, Vincent mailto [Université de Liège - ULg > Département des sciences biomédicales et précliniques > Génétique générale et humaine]
May-2007
European Journal of Clinical Investigation
Blackwell Publishing
37
Suppl. 1
79
Yes (verified by ORBi)
International
0014-2972
Oxford
European Society of Clinical Investigation meeting, Uppsala
du 1 mai 2007 au 3 mai 2007
[en] Infliximab
Researchers ; Professionals
http://hdl.handle.net/2268/5283

There is no file associated with this reference.

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.